Study identity card

EU-PROACT

France Norway Spain Belgium Italy United Kingdom Ireland Austria The Netherlands Switzerland
Share
  • Disease: Acute SARS-CoV-2, Avian Influenza, Influenza
  • Study type: Adaptive Platform Trial
  • Study aim: To establish a pan-European network for respiratory viral infections, focusing on syndromic approaches and integrating clinical trials, laboratory surveillance, methodological support, preparedness tools, social science research, and public health education
  • Number of participants enrolled: Enrollment ongoing
  • Study enrolling from

Study Data

  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza

Other information

Funders:

  • Horizon Europe

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to